Download

ORIGINAL ARTICLE

Biofunctional activity and phytochemical composition by LC-QToF-MS of Mitragyna speciosa Korth leaves extracted in Northern Thailand

Pichamon Yana1, Peerapong Jeeno2, Sumed Yadoung1,3, Udomsap Jaitham2, Titi Phanjaroen2,4, Surat Hongsibsong1,2*

1Environment, Occupational Health Sciences and Non-Communicable Disease Center of Excellence, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand;

2School of Health Sciences Research, Research Institute for Health Sciences, Chiang Mai University, Chiang Rai, Thailand;

3Environmental Science Program, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand;

4Department of Traditional Chinese Medicine, School of Integrative Medicine, Mae Fah Luang University, Mueang, Chiang Rai, Thailand

Abstract

Mitragyna speciosa Korth, a traditional Thai herb, is known for its medicinal properties, including enhancing physical strength and promoting relaxation. However, its misuse can lead to addiction. This study evaluated the antioxidant capacity, anti-inflammatory activity, and chemical composition of M. speciosa using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QToF-MS). Leaves were extracted with ethanol, methanol, and water. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay showed that ethanol extraction had the best IC50 value (0.23 ± 0.01 mg/mL). Methanol extraction excelled in the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay (2.24 ± 0.33 mg/mL), while water extraction displayed the highest antioxidant capacity in the fluorescence recovery after photobleaching (FRAP) assay (231.87 ± 11.51 mg ascorbic acid equivalent [AAE]/100 g). The water extract exhibited the highest total phenolic content (153.41 ± 0.06 mg gallic acid equivalent [GAE]/g) and total flavonoid content (6.24 ± 0.83 mg QE/g). It also provided the maximum anti-inflammatory protection, with a protection rate of 96.35% and a hemolysis of 3.65%. LC-QToF-MS analysis identified key bioactive compounds, such as stigmatellin Y (99.17%) and mitragynine (98.58%), along with other compounds with antioxidant and anti-inflammatory activities. These findings highlight M. speciosa’s potential of being a therapeutic agent. Future research should focus on elucidating the molecular mechanisms of its bioactive compounds, optimizing extraction techniques, and conducting in vivo and clinical studies to validate its safety and therapeutic efficacy.

Key words: Mitragyna speciosa Korth, antioxidant activity, anti-inflammatory, flavonoid, phenolic, LC-QToF-MS

*Corresponding Author: Surat Hongsibsong, School of Health Sciences Research, Research Institute for Health Sciences, No. 5, Office of the University, Chiang Mai University, Chiang Mai, Thailand. Email: surat.hongsibsong@cmu.ac.th

Academic Editor: Carlos A.F. Oliveira, PhD., Department of Food Engineering, School of Animal Science and Food Engineering, University of São Paulo, Brazil

Received: 7 August 2024; Accepted:10 December 2024; Published: 7 February 2025

DOI: 10.15586/qas.v17i1.1526

© 2025 Codon Publications
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/)

Introduction

The herbal leaves of Mitragyna speciosa Korth (MSK) comes from a tree of the Rubiaceae or coffee family. It is a native of Southeast Asia’s humid tropical regions, such as Thailand, Malaysia, Indonesia, the Philippines, etc. MSK is a tropical evergreen tree of the genus Mitragyna that can grow to a height of 25 m. Its trunk might achieve a diameter of 0.9 m. The outer bark is smooth and gray, and the trunk is usually straight. The leaves are glossy and dark green, with an ovate-acuminate form and opposing growth pattern. They can reach a length of over 14–20 cm and a width of 7–12 cm. Their vein count ranges from 12 to 17 (Nakaphan et al., 2016; Veltri and Grundmann, 2019). Additionally, MSK has opioid properties and has some stimulant-like effect to be used as a medicine to treat diseases (Eastlack et al., 2020).

In Thailand, there are three species of kratom: geen, red, and white. Depending on its usage, each species has different flavors and significant compounds. In the industry, the MSK red species are highly sought after because of their potential for industrial processing and application as a medicinal herb. The red variety is known to help manage diabetes and is used to treat dysentery, diarrhea, and stomachache (Goh et al., 2021). Commonly, the leaves are either chewed afresh or grilled and added to food, providing energy to the body and helping individuals endure prolonged exposure to sun without fatigue (Ponglux et al., 1994). The effects usually start within 5–10 min and can last from 2 to 5 h. However, improper use or consumption can lead to addiction and adverse effects, including dry mouth, frequent urination, loss of appetite, constipation, insomnia, dizziness, and vomiting (Azizi et al., 2010).

The legislation of Mitragyna speciosa in Thailand marks a significant shift in policy, allowing for its personal use and cultivation. However, safety concerns remain, particularly related to potential misuse, dependency, and the unregulated marketing. The Thai government is moving toward a regulated framework, but public health monitoring and international legal considerations continue to be important with the increase of kratom usage (Khalil et al., 2020).

The leaves of the MSK contain more than 40 structurally related alkaloids along with several flavonoids, terpenoid saponins, polyphenols, and various glycosides. The primary psychoactive compounds in these leaves are mitragynine and 7-hydroxymitragynine, both being effective in pain relief (Racho et al., 2022; Salim et al., 2021). Furthermore, MSK leaf extract has been shown to possess antioxidant and antibacterial properties, effectively targeting Salmonella typhi and Bacillus subtilis. It also effectively inhibits the growth of Escherichia coli and S. pneumoniae. However, research on MSK has been extensively conducted to explore its antioxidant properties, chemical composition, and pharmaceutical potential. This plant is extensively used in various countries, such as Malaysia, Indonesia, Myanmar, and the Philippines (Firmansyah et al., 2021; Sengnon et al., 2023; Zakaria et al., 2023). Therefore, investigating MSK, particularly in Thailand, where it is utilized frequently, is crucial to understand its medicinal benefits.

This study aimed to investigate the phytochemical profile of MSK, a red strain from Chiang Mai Province of Northern Thailand. The research focused on evaluating antioxidant activity using 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and fluorescence recovery after photobleaching (FRAP) assays as well as quantifying total phenolic content (TPC) and total flavonoid content (TFC). Additionally, the study explored the anti-inflammatory properties of leaves extract. Advanced liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QToF-MS) analysis was applied to identify primary compounds and characterize the chemical composition of Northern Thailand’s MSK leaf extracts.

Materials and Method

Plant material

The fresh plant leaves of red species of MSK were collected from Ban Chomphu, subdistrict Chomphu, district Saraphi, Chiang Mai Thailand (latitude: 18.7201203, and longitude: 99.0670545) in June 2021. Authentication of plant leaves of red species was done by the Department of Agriculture, Thailand.

Extraction of plant sample

The method described by Jeeno et al. (2022) was used for extraction. Fresh herb leaves were finely chopped, and 1 g of the crushed material was extracted with 30 mL of distilled water, ethanol, and 99% methanol. The prepared combination was kept at room temperature (25°C) for 3 days. After the soaking period, the samples were agitated at 2500 rpm for 5 min and subsequently filtered using Whatman No. 1 filter paper. The filtered samples were concentrated to dryness by using a rotary evaporator. The resulting crude extracts were weighed and reconstituted in dimethyl sulfoxide. Before analysis, the extracted crude material was stored in a refrigerator at 4°C.

Figure 1. The fresh plant leaves of red species of Mitragyna speciosa Korth.

DPPH radical scavenging activity

The MSK extract’s scavenging activity of free radicals was assessed using the technique outlined by Jeeno et al. (2022). With some slight modifications, the DPPH) assay was performed. To make DPPH stock solution, 24 mg of DPPH was dissolved in 100 mL of methanol. By adding 45 mL of methanol to a working DPPH solution that contained 10 mL of DPPH stock solution, the absorbance was changed to 1.1 at 517 nm. On a 96-well plate, 100 µL of DPPH working solution and 100 µL of plant extract solution were combined. A micro-titer-plate reader was used to measure absorbance at 517 nm after 30 min of incubation in the dark. The percentage of DPPH free radical scavenging activity was calculated using the following formula:

DPPH = ([A control - A sample]/A control) × 100,

where A control and A sample are the absorbance reading of control and sample, respectively. The inhibitory concentration at 50% (IC50) value for DPPH free radical scavenging activity corresponds to the sample concentration necessary to inhibit 50% of DPPH free radicals. IC50 was determined graphically from the curve plot between the percentages of DPPH scavenging activity and the sample concentration (Kek et al., 2017).

ABTS radical scavenging activity

The ABTS method was used to determine the antioxidant activity potential based on the procedure described by Jeeno et al. (2022). The ABTS reagent used trolox as a stable radical in an aqueous solution. The value of correlation between the concentration of the sample and the percentage of ABTS that inhibits it is reported as IC50, or absorbance read at a wavelength of 734 nm. The ABTS radical was created by the reaction of 2.45-mM potassium persulfate with 7-mM ABTS in H2O, which was then kept at 25°C in the dark for 12–16 h prior to use. After that, an absorbance of 0.7±0.02 at 734 nm was obtained by diluting the ABTS solution with 80% ethanol. The ABTS working solution of 190 µL was added to a 96-well plate containing 10 µL of plant extract. After incubation in the dark for 10 min, the absorbance was measured at 734 nm. Percentage inhibition of absorbance at 734 nm was calculated using the following formula:

ABTS radical scavenging effect (%) = (Ab - Aa/Aa) × 100,

where Ab is the absorbance of ABTS radical + methanol; Aa is the absorbance of ABTS radical + sample extract/standard. Trolox was used as a standard radical (Arnao et al., 2001).

Ferric ion-reducing antioxidant power

The FRAP assay was performed using the method described by Jeeno et al. (2022). Concisely, FRAP reagent was combined with 2.5 mL of 2,4,6-tripyridyl-S-triazine (TPTZ) solution in 40-mM HCl, 2.5 mL of ferric chloride, and 25 mL of 300-mM acetate buffer at pH 3.6. The plant extract solution, 1 g, was diluted twice with distilled H2O, and aliquots of 10 µL of plant extracted solution were combined with 190 µL of FRAP reagent on a 96-well microtiter plate. The sample’s absorbance was measured after 30 min in the dark at 593 nm with a microtiter-plate reader. The standard curve was created using ascorbic acid, and FRAP value was determined by comparing it to the standard curve. The result was expressed as “mg ascorbic acid equivalent/100 g” (mg AAE/100 g) of plant extract (Arnao et al., 2001).

Total phenolic content

The TPC was calculated by using Folin–Ciocalteau reagent (FCR) (Dewanto et al., 2002; Jeeno et al., 2022). The method used gallic acid as a standard substance. Different concentrations of gallic acid were prepared in 80% methanol at concentrations of 0.02–0.64 mg/mL, adding 12.5 µL of the sample and 12.5 µL of FCR (diluted with 10 times distilled H2O) for 6 min; 7% sodium carbonate was added to 100-µL distilled water to prepare 125-µL volume. The solution was allowed to react at room temperature for 9 min. Then the absorbance was measured at a wavelength of 760 nm and the concentration of TPC was estimated using calibration curves. Results were expressed as “mg of gallic acid equivalent/gram” (mg GAE/g) of of dry sample extract.

Total flavonoids content

The TFC was measured by the color test method as described by Jeeno et al. (2022). With modification, 25-µL sample solution was put into a 96-well plate, and 7.5-µL sodium nitrite solution (7%) and 12.5-µL distilled H2O were added and mixed thoroughly. The solution was allowed to stand at 25°C for 5 min. Then, 15 µL of 10% aluminum chloride solution was added, and the mixture was mixed thoroughly and kept at 25°C for 5 min. Finally, 50 µL of 1-M sodium hydroxide solution and 27.5-µL distilled water were added, mixed thoroughly and kept at 25°C for 5 min. The absorbance was measured immediately at 510 nm using a spectrophotometer measured against H2O blank, and the concentration of flavonoids was estimated using calibration curves. Results were expressed as “mg of Quercetin equivalent/gram” (mg QE/g) of sample.

Anti-inflammatory properties

The human red blood cell (HRBC) membrane stabilization method was adapted from Chippada et al. (2011). Plant solution was prepared at 100-µg/mL concentration in buffer solution (pH 7.4). Alsever solution was added to the blood samples collected from volunteers. The mixture was gently shaken and centrifuged at 3000 rpm for 20 min at 4°C. RBCs were collected, and sodium chloride (NaCl) solution was added to the pellet. After gently shaking to mix, the sample was centrifuged again at 3000 rpm for 20 min at 4°C. Then the washed RBCs were collected and stored for analysis. To prepare 10% v/v HRBC solution, 9 mL of NaCl solution was added to 1 mL of washed RBCs, and the mixture was slowly shaken to achieve uniformity. For sample analysis in a test tube, the following were added: 1 mL of buffer solution (pH 7.4), 2 mL of NaCl solution, 0.5 mL of 10% v/v HRBC solution, and 0.5 mL of plant sample solution. The contents were slowly mixed and incubated at 37°C for 30 min in a water bath. After incubation, the sample was centrifuged at 3000 rpm for 10 min. The absorbance of supernatant was measured at 560 nm. Control samples consisted of 10% v/v HRBC solution and distilled water. The percentages of protection and hemolysis were calculated using Equation (1) and Equation (2), respectively.

Calculation method:

Protection (%) = 100 - ([A1/A0] × 100), (1)

Hemolysis (%) = ([A1/A0] × 100), (2)

where A0 = absorbance of the control, and A1 = absorbance of the sample.

LC-QToF-MS analysis of chemical composition

The qualitative dataset of the extracted sample was characterized by using LC-QToF-MS analysis positive mode where molecules are ionized by gaining a positive charge according to the method used by Jeeno et al. (2022). In brief, the extracted samples were dissolved in 1-mL methanol (LC-MS grade) and cleaned by using a Dispersive Kit, (Fruits and Vegetables with Pigments and Fats, AOAC method, 2 mL, 100/pk. Contains: 50 mg PSA, 50 mg GCB, 50 mg C18EC, 150 mg MgSO4, Agilent Technology, Santa Clara, CA, USA). The sample solution was filtered through a 0.22-μm filter. The qualitative dataset was performed by using an Agilent 6500 series Q-TOF instrument (Agilent Technology) consisting of a degasser, binary pump, column oven, and thermostat autosampler. The instrument settings were optimized as follows: LC conditions, 0.2 mL/min flow rate; injection volume of 10 μL; and a gradient mobile system starting with 5% ACN and 95% water (1% formic acid) for 30 min. The chromatographic separation was accomplished using a ZORBAX Eclipse Plus C18 (2.1×150 mm, 1.8 µm). The MS conditions involved an electrospray ionization (ESI) probe in positive mode. The nebulizer was operated at 20 psi with 7 L/min nitrogen flow. The capillary temperature was kept at 300°C, and the flow rate was set at 8 μL/min. The range of mass divided by charged number of ions (m/z) was 50–1000, the capillary voltage was 4500 V, and the dry heater temperature was 280°C. The data were used to score the match of ions with the MassHunter METLIN Metabolomics Database. MassHunter Qualitative Analysis software (version 10.0, Agilent Technologies, Santa Clara, CA, USA) was used to perform a find-by-formula search within the databas. The chemical parameters of compounds were determined using the Medlin Library.

Results

Antioxidant activity

The antioxidant activity of MSK was evaluated using DPPH, ABTS, and FRAP assays. DPPH results showed that ethanolic extract had the strongest free radical scavenging ability (IC50 = 0.23 mg/mL), followed by methanolic extract (0.29 mg/mL), while the water extract was less effective (1.81 mg/mL). ABTS assay results indicated methanolic extract had the highest radical scavenging activity (IC50 = 2.24 mg/mL), compared to ethanolic and water extracts. In FRAP assay, water extract showed the greatest reducing power (231.87 mg AAE/100 g), surpassing both ethanolic and methanolic extracts (Table 1).

Table 1. DPPH scavenging activity, ABTS radical scavenging activity, and FRAP extract of MSK.

Mitragyna speciosa Korth DPPH (mg/mL) ABTS (mg/mL) FRAP
IC50 IC50 (mg AAE/100 g)
Ethanol extracted 0.23 ± 0.01a 3.14 ± 0.70a,b 113.48 ± 3.79a
Methanol extracted 0.29 ± 0.01a 2.24 ± 0.33a 53.05 ± 6.77a
Water extracted 1.81 ± 0.40b 3.97 ± 0.62b 231.87 ± 11.51a

DPPH: 2,2-diphenyl-1-picrylhydrazyl; ABTS: 2,2-casino-bis(3-ethylbenzothiazoline-6-sulfonic acid); FRAP: ferric ion reducing antioxidant power.

The results are presented as mean values ± standard deviation.

Different superscripted letters within the same column indicate a significant difference in antioxidant activity between extraction method using the one-way ANOVA statistical test.

Total phenolic content and total flavonoid content

The TPC and TFC of MSK leaf extracts are presented in Table 2. The water extract exhibited the highest TPC value at 153.41 ± 0.06 mg GAE/g, followed by the methanol extract at 135.17 ± 0.10 mg GAE/g and the ethanol extract at 131.66 ± 0.04 mg GAE/g. Regarding TFC, the methanol extract showed the highest value at 2.20 ± 0.58 mg QE/g, followed by the ethanol extract at 4.97 ± 0.01 mg QE/g and the water extract at 6.24 ± 0.83 mg QE/g.

Table 2. Total phenolic content and total flavonoid content of MSK extracts.

   Mitragyna speciosa Korth
Sample Ethanol extracted Methanol extracted Water extracted
Total phenolic compound (mg GAE/g) 131.66 ± 0.04a 135.17 ± 0.10a 153.41 ± 0.06a
Total flavonoid content (mg QE/g) 2.20 ± 0.58a,b 4.97 ± 0.01a 6.24 ± 0.83b

The results are presented as mean values ± standard deviation.

Different superscripted letters within the same column indicate a significant difference in TPC and TFC between extraction method using the one-way ANOVA statistical test.

Anti-inflammatory properties

The results of the anti-inflammatory efficacy study, measured by the suppression of hypotonicity-induced hemolysis in HRBC membranes, indicate that the water extract of MSK leaves exhibited the highest protective effect at all tested concentrations (Table 3). At 100 µg/mL, the water extract achieved the maximum protection of 96.35% with only 3.65% hemolysis. Comparatively, the ethanol extract showed 94.73% protection with 5.27% hemolysis at 100 µg/mL, and the methanol extract displayed 92.85% protection with 7.15% hemolysis at the same concentration. These findings suggested that the water extract of MSK leaves was effective in stabilizing HRBC membranes and preventing hemolysis, thereby indicating its superior anti-inflammatory potential, compared to ethanol and methanol extracts.

Table 3. Anti-inflammatory potential of MSK leaf extracts.

Mitragyna speciosa Korth Concentration (µg/mL) Protection (%) Hemolysis (%)
Ethanol extracted 100 94.73 ± 2.29a 5.27 ± 2.29
Methanol extracted 100 92.85 ± 2.46a 7.15 ± 2.46
Water extracted 100 96.35 ± 0.15a 3.65 ± 0.15

The results are presented as mean values ± standard deviation.

Different superscripted letters within the same column indicate a significant difference in anti-inflammatory efficacy between extraction methods using the one-way ANOVA statistical test.

Chemical composition by LC-QToF-MS

The LC-QToF-MS analysis of active MSK compounds extracted with methanol showed the precise mass of molecular formula and the anticipated isotope pattern for that formula. The MassHunter qualitative analysis software find-by-formula search of the Agilent MassHunter METLIN Metabolomics Database used this data to score the match of ions with positive mode database. Phytochemical analysis of MSK leaf extracts was conducted using LC-QToF-MS, and the results are summarized in Table 4, and the LC-QToF-MS chromatograms are shown in Figure 2. The top nine compounds with a higher matching score (93.02–99.17%) were cinnamtannin A1, procyanidin B1, 6-hydroxykaempferol 7-rutinoside, biorobin, rhodomycin D, kaempferol 3-O-β-D-glucosyl-(1->2)-β-D-glucoside, alpinine, mitragynine, and stigmatellin Y. MSK leaf extracts showed a potential of metabolite, anti-inflammatory agent, antioxidant, and lipoxygenase inhibitor.

Table 4. Compounds identified from the extract of MSK methanolic leaves according to LC-QToF-MS.

No. Compound Formula RT (min) Matching score (%) m/z Mass
1. Cinnamtannin A1 C45 H38 O18 0.684 96.44 867.21287 866.20554
2. Procyanidin B1 C30H26O12 0.693 96.03 579.14948 578.14227
3. 6-Hydroxykaempferol 7-rutinoside C27 H30 O16 0.694 97.49 611.16068 610.15351
4. Biorobin C27 H30 O15 0.697 94.95 595.16581 594.15879
5. Rhodomycin D C28 H31 N O11 0.702 93.02 575.22429 557.19032
6. Kaempferol 3-O-β-D-glucosyl-(1->2)-β-D-glucoside C27 H30 O16 0.718 95.7 633.14237 610.15322
7. Alpinine C23 H29 N O6 0.736 98.55 433.23365 415.19979
8. Mitragynine C23 H30 N2 O4 0.818 98.58 399.2284 398.22114
9. Stigmatellin Y C29 H40 O6 2.742 99.17 579.14993 484.28274

Figure 2. LC-QToF-MS analysis of the top nine compounds in terms of matching scores of MSK methanolic extract. (A) LC-QToF-MS chromatogram; No. 1. mass spectrum ofcinnamtannin A1; No. 2. procyanidin B1; No. 3. 6-hydroxykaempferol 7-rutinoside.

Figure 2. (Continued) LC-QToF-MS analysis of the top nine compounds in terms of matching scores of MSK methanolic extract. (A) LC-QToF-MS chromatogram; No. 4. biorobin; No. 5. rhodomycin D; No. 6. kaempferol 3-O-β-D-glucosyl-(1->2)-β-D-glucoside; No. 7. Alpinine.

Figure 2. (Continued) LC-QToF-MS analysis of the top nine compounds in terms of matching scores of MSK methanolic extract. (A) LC-QToF-MS chromatogram; No. 8. mitragynine; and No. 9. stigmatellin Y.

Discussion

Evaluation of antioxidant properties

The antioxidant properties of MSK extracts showed significant variation depending on the solvent used for extraction. The ethanol extract exhibited the highest antioxidant activity in the DPPH assay (IC50 = 0.23 ± 0.01 mg/mL), probably because of its efficient extraction of phenolic compounds. In contrast, the methanol extract demonstrated superior ABTS radical scavenging activity (IC50 = 2.24 ± 0.33 mg/mL), suggesting it may extract a different set of phenolic compounds with greater ABTS activity. Although the water extract exhibited lower activity in the DPPH and ABTS assays, it demonstrated the highest reduction power in FRAP assay (231.87 ± 11.51 mg AAE/100 g), indicating a strong electron-donating capacity. Additionally, it yielded the highest values in the analysis of TPC (153.41 ± 0.06 mg GAE/g) and TFC (6.24 ± 0.83 mg QE/g). These results were consistent with the results of the previous studies on plant leaf extracts, where solvent polarity significantly influenced extraction efficiency and antioxidant activities (Benjakul et al., 2014; Tagrida and Benjakul, 2021). The strong antioxidant activity of MSK extracts, particularly in the FRAP assay, proposed their potential for health benefits related to oxidative stress mitigation. These findings underscored the importance of solvent selection in optimizing the extraction of bioactive compounds from plant materials.

Analysis of TPC and TFC

The comparison of TPC and TFC in MSK leaf extracts from different regions illustrated the significant role of geographical origin, extraction methods, and environmental conditions in shaping phytochemical profiles. In this study, MSK leaf extracts from Northern Thailand exhibited a higher TPC (135.17 ± 0.10 mg GAE/g) and lower TFC (4.97 ± 0.01 mg QE/g), compared to the prior findings of Parthasarathy et al. (2009), who reported a TPC of 105.6 mg GAE/g and a TFC of 91.1 mg CAE/g in samples collected from Perak, Malaysia. This variation could be attributed to Northern Thailand’s unique climatic and soil conditions that could promote higher phenolic content, enhancing the antioxidant potential of MSK leaf extracts. Furthermore, the aqueous extract from Northern Thailand demonstrated a superior TPC (153.41 ± 0.06 mg GAE/g), highlighting water’s efficacy as an extraction solvent, as it yielded higher phenolic content than previously reported in studies, such as Kang et al. (2010). These findings emphasized the need to optimize extraction techniques and consider regional differences to fully harness the therapeutic potential of MSK, making it a promising source of natural antioxidants with potential applications in health and medicine.

Assessment of anti-inflammatory potential

The anti-inflammatory potential of MSK leaf extracts, especially the aqueous extract, was demonstrated by their ability to stabilize RBC membranes under osmotic stress. This extracellular antioxidant effect, which was discovered by Shaik Mossadeq et al. (2009), showed that the methanolic extract of MSK exhibited anti-inflammatory and analgesic effects via inhibition of cyclooxygenase and lipoxygenase. Our study highlighted the role of phenolic compounds in aqueous extract, which was consistent with the anti-inflammatory activity of flavonoids and saponins reported in previous studies. It is well recognized that these biocomponents suppress pro-inflammatory mediators, which aid in the stabilization of cell membranes. Previous studies linking phenolic content to improved anti-inflammatory efficacy (Hassan et al., 2013) further corroborated this finding, emphasizing the MSK aqueous extract’s ability to stabilize outer membranes. These findings highlighted the potential for versatile approaches to treat inflammation by MSK, making it a strong candidate for more comprehensive therapeutic applications. Our findings elaborated the therapeutic potential of MSK and offered potential therapeutic advantages for diseases associated with impaired cell membrane integrity.

Phytochemical profiling by LC-QToF-MS

The main substances and chemical components of MSK were investigated using the LC-QToF-MS technique and it was found that stigmatellin Y had a matching rate of 99.17%. Stigmatellin Y is a powerful inhibitor that targets the quinol oxidation (QO) site in the cytochrome bc1 complex within mitochondria and the cytochrome b6f complex in thylakoid membranes.

Mitragynine had a matching rate of 98.58%. Mitragynine, an indole-based alkaloid, is a primary active compound found in the Southeast Asian plant Mitragyna speciosa, commonly known as kratom. The dried leaves of kratom contain a total alkaloid concentration ranging from 0.5% to 1.5%.

In Thai varieties, mitragynine is the predominant component, making up as much as 66% of the total alkaloid content (Handa et al., 2008). Mitragynine has garnered interest for its potential medicinal properties. It is an in-dole-based compound that offers various therapeutic properties, such as pain relief, mood enhancement, and opioid withdrawal symptom alleviation (Rech et al., 2015). However, despite its potential benefits, the use of mitragynine in medicine is still under study, and it is important to consider its legal status and possible adverse effects. In a previous study characterizing mitragynine using LC-QToF-MS, it was found that it has analgesic properties. Its mechanism of action involves interaction with opioid receptors, leading to opioid-like effects, such as sedation, euphoria, and pain relief. Consequently, for testing in the opioid group, the M. speciosa was utilized instead of specific substances or medications targeting the nervous system. (Chear et al., 2021; Matsumoto et al., 2006).

Additionally, MSK has been shown to have anti-inflammatory and antioxidant properties. The bioactive compounds, such as Cinnamtannin A1, Procyanidin B1, and 6-hydroxykaempferol 7-rutinoside, were identified in MSK, all of which possess antioxidant properties and offer health benefits (Colucci et al., 2019). Procyanidin B1 can be transformed into procyanidin A1 through radical oxidation by DPPH radicals under neutral conditions. Alpinine has also been studied for its diverse pharmacological activities, such as potential antioxidant, anti-inflammatory, and antimicrobial effects. However, variations in chemotypes, climate, environmental stressors, and soil types can significantly alter the concentration of mitragynine, contributing to differences in the primary ingredient content (Handa et al., 2008).

Conclusion

This study highlighted the antioxidant and anti-inflammatory properties of MSK. Water extraction showed the highest antioxidant capacity and anti-inflammatory protection, while ethanol and methanol extracts excelled in specific antioxidant assays. The key bioactive compounds, including stigmatellin Y and mitragynine, were identified through LC-QToF-MS, underscoring the herb’s medicinal potential. The findings suggested that Mitragyna speciosa could be a valuable source of natural antioxidants and anti-inflammatory agents. Future research should focus on understanding its bioactive compounds’ molecular mechanisms, optimizing extraction methods, and conducting in vivo and clinical studies to validate its therapeutic potential and safety.

Acknowledgments

The authors thank the Research Institute for Health Science, Chiang Mai University for its support in the analysis.

Author Contributions

Conceptualization: Pichamon Yana and Surat Hongsibsong; Methodology: Titi Phanjaroen and Surat Hongsibsong; Validation: Pichamon Yana, Peerapong Jeeno, and Sumed Yadoung; Formal analysis: Pichamon Yana, Peerapong Jeeno, and Sumed Yadoung; Investigations: Sumed Yadoung and Surat Hongsibsong; Resources: Surat Hongsibsong; Data curation: Peerapong Jeeno, Pichamon Yana, Sumed Yadoung, and Udomsap Jaitham; Writing—original draft preparation: Pichamon Yana; Writing—review and editing: Titi Phanjaroen and Surat Hongsibsong; Visualization: Pichamon Yana; Supervision: Surat Hongsibsong; Project administration: Sumed Yadoung; and Funding acquisition: Surat Hongsibsong. All authors had read and agreed to the published version of the manuscript.

Conflict of Interest

The authors declared no conflict of interest.

Funding

This research was supported by the Postmaster Proactive Research Fund 2024, Chiang Mai University.

REFERENCES

Arnao, M.B., Cano, A., and Acosta, M. 2001. The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chemistry 73(2): 239–244. 10.1016/S0308-8146(00)00324-1

Azizi, J., Ismail, S., Mordi, M.N., Ramanathan, S., Said, M.I.M., and Mansor, S.M. 2010. In vitro and in vivo effects of three different Mitragyna speciosa Korth leaf extracts on phase II drug metabolizing enzymes—glutathione transferases (GSTs). Molecules 15(1): 432–441. 10.3390/molecules15010432

Benjakul, S., Kittiphattanabawon, P., Sumpavapol, P., and Maqsood, S. 2014. Antioxidant activities of lead (Leucaena leucocephala) seed as affected by extraction solvent, prior dechlorophyllisation and drying methods. Journal of Food Science and Technology 51: 3026–3037. 10.1007/s13197-012-0846-1

Chear, N.J-Y., León, F., Sharma, A., Kanumuri, S.R.R., Zwolinski, G., Abboud, K.A., Singh, D. et al. 2021. Exploring the chemistry of alkaloids from Malaysian Mitragyna speciosa (Kratom) and the role of oxindoles on human opioid receptors. Journal of Natural Products 84(4): 1034–1043. 10.1021/acs.jnatprod.0c01055

Chippada, S.C., Volluri, S.S., Bammidi, S.R., and Vangalapati, M. 2011. In vitro anti-inflammatory activity of methanolic extract of Centella asiatica by HRBC membrane stabilisation. Rasayan Journal of Chemistry 4(2): 457–460.

Colucci, S., Culbreth, S., Alsarraf, E., and Fanikos, J. 2019. Why does the food and drug administration need to ban kratom. Current Emergency and Hospital Medicine Reports 7: 169–174. 10.1007/s40138-019-00201-5

Dewanto, V., Wu, X., Adom, K.K., and Liu, R.H. 2002. Thermal processing enhances the nutritional value of tomatoes by increasing total antioxidant activity. Journal of Agricultural and Food Chemistry, 50(10): 3010–3014. 10.1021/jf0115589

Eastlack, S.C., Cornett, E.M., and Kaye, A.D. 2020. Kratom—pharmacology, clinical implications, and outlook: a comprehensive review. Pain and Therapy 9: 55–69. 10.1007/s40122-020-00151-x

Firmansyah, A., Sundalian, M., and Taufiq, M. 2021. Kratom (Mitragyna speciosa Korth) for a new medicinal: a review of pharmacological and compound analysis. Biointerface Research in Applied Chemistry, 11(2): 9704–9718. 10.33263/BRIAC112.97049718

Goh, Y.S., Karunakaran, T., Murugaiyah, V., Santhanam, R., Abu Bakar, M.H., and Ramanathan, S. 2021. Accelerated solvent extractions (ASE) of Mitragyna speciosa Korth (Kratom) leaves: evaluation of its cytotoxicity and antinociceptive activity. Molecules 26(12): 3704. 10.3390/molecules26123704

Handa, S.S., Khanuja, S.P.S., Longo, G., and Rakesh, D.D. 2008. “Extraction Technologies for Medicinal and Aromatic Plants,” No. 66. United Nations Industrial Development Organization, Vienna, Austria, and International Centre for Science and High Technology. Trieste, Italy, pp. 21–25.

Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, N.H., Suhaimi, F.W., Vadivelu, R. et al. 2013. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37(2): 138–151. 10.1016/j.neubiorev.2012.11.012

Jeeno, P., Tongban, S., Yana, P., Wongta, A., Sutan, K., Yadoung, S., and Hongsibsong, S. 2022. Tentative identification of phytochemicals from Smilax glabra and Smilax corbularia extracts by LC-QToF-MS and their bioactive potential. Plants 11(16): 2089. 10.3390/plants11162089

Kang, W.Y., Li, C.F., and Liu, Y.X. 2010. Antioxidant phenolic compounds and flavonoids of Mitragyna rotundifolia (Roxb.) Kuntze in vitro. Medicinal Chemistry Research 19: 1222–1232. 10.1007/s00044-009-9265-x

Kek, S.P., Chin, N.L., Yusof, Y.A., Tan, S.W., and Chua, L.S. 2017. Classification of entomological origin of honey based on its physicochemical and antioxidant properties. International Journal of Food Properties 20(Sup 3): S2723–S2738. 10.1080/10942912.2017.1359185

Khalil, S., Abdullah, S.A.J., and Ahmad, R. 2020. Enforcement status of the Poison Act 1952 against offences related to kratom (Mitragyna speciosa Korth) misuse in Malaysia. UUM Journal of Legal Studies (UUMJLS) 11(1): 75–93. 10.32890/uumjls.11.1.2020.6928

Matsumoto, K., Hatori, Y., Murayama, T., Tashima, K., Wongseripipatana, S., Misawa, K., and Horie, S. 2006. Involvement of μ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. European Journal of Pharmacology 549(1–3): 63–70. 10.1016/j.ejphar.2006.08.013

Nakaphan, T., Teerachaisakul, M., Puttum, S., Sompimai, K., and Nootim, P. 2016. Traditional uses of kratom (Mitragyna speciosa Korth) among folk healers in southern Thailand. Journal of Traditional Thai and Alternative Medicine 14(3): 274–285.

Parthasarathy, S., Azizi, J.B., Ramanathan, S., Ismail, S., Sasidharan, S., Said, M.I.M., and Mansor, S.M. 2009. Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. Molecules 14(10): 3964–3974. 10.3390/molecules14103964

Ponglux, D., Wongseripipatana, S., Takayama, H., Kikuchi, M., Kurihara, M., Kitajima, M., ... & Sakai, S.I. 1994. A new indole alkaloid, 7 α-hydroxy-7H-mitragynine from Mitragyna speciosa in Thailand. Planta Medica, 60(06): 580–581. 10.1055/s-2006-959578

Racho, M.M.M., Narceda, R.J.A., and Uy, S.P Jr. 2022, Oct. Hierarchical cluster analysis potential application on suspected plant-based new psychoactive substances (NPS) found in the Philippines using FT-IR/ATR spectral data. Forensic Asia 12: 11–16.

Rech, M.A., Donahey, E., Cappiello Dziedzic, J.M., Oh, L., and Greenhalgh, E. 2015. New drugs of abuse. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35(2): 189–197. 10.1002/phar.1522

Salim, H.M., Puspitarini, M.D., Setiwati, Y., and Shimabukuro, M. 2021. Antibacterial mechanism of Kratom (Mitragyna speciosa) methanol extract on Streptococcus pneumoniae and Eschericia coli bacteria. Biomolecular and Health Science Journal 4(2): 99–103. 10.20473/bhsj.v4i2.28933

Sengnon, N., Vonghirundecha, P., Chaichan, W., Juengwatanatrakul, T., Onthong, J., Kitprasong, P., and Wungsintaweekul, J. 2023. Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand. Plants, 12(4): 949. 10.3390/plants12040949

Shaik Mossadeq, W.M., Sulaiman, M.R., Tengku Mohamad, T.A., Chiong, H.S., Zakaria, Z.A., Jabit, M.L., ..., and Israf, D.A. 2009. Anti-inflammatory and antinociceptive effects of Mitragyna speciosa Korth methanolic extract. Medical Principles and Practice 18(5): 378–384. 10.1159/000226292

Tagrida, M., and Benjakul, S. 2021. Betel (Piper betle L.) leaf ethanolic extracts dechlorophyllized using different methods: antioxidant and antibacterial activities, and application for shelf-life extension of Nile tilapia (Oreochromis niloticus) fillets. RSC Advances, 11(29): 17630–17641. 10.1039/D1RA02464G

Veltri, C., and Grundmann, O. 2019. Current perspectives on the impact of Kratom use. Substance Abuse and Rehabilitation 10: 23–31. 10.2147/SAR.S164261

Zakaria, F., Anuar, N.N.M., Hisam, N.S.N., Tan, J.K., Zakaria, F., Fauzi, S.M.M., and Ashari, S.E. 2023. An investigation of the in vitro wound healing potential of Mitragyna speciosa (Korth.) Havil leaf ultrasound-assisted methanol crude extract and fractions. Biocatalysis and Agricultural Biotechnology 50: 102707. 10.1016/j.bcab.2023.102707